GeneDx Holdings WGS
NASDAQ WGS
$56.15 -10.99 (-16.37%)
At close: Oct 23, 2026 · 4:00 PM EDT

GeneDx Holdings (WGS) Gains from Sales and Divestitures (2023)

Updated

GeneDx Holdings (WGS) reported Gains from Sales and Divestitures of -$1.28 million for Q4 2023.

Analysis

GeneDx Holdings (WGS) Gains from Sales and Divestitures (2023) Analysis & Trends

For FY2023, GeneDx Holdings posted Gains from Sales and Divestitures of $1.68 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 102.25 Bn 101.69 Bn -
2 Natera 58.01 Bn 53.69 Bn 485.19 Mn
3 Labcorp Holdings 26.62 Bn 24.38 Bn 1.11 Bn
4 Quest Diagnostics 26.61 Bn 24.70 Bn 1.04 Bn
5 Guardant Health 22.59 Bn 18.65 Bn 219.03 Mn
6 Tenet Healthcare 21.62 Bn 12.76 Bn -
7 Fresenius Medical Care AG 12.67 Bn 5.74 Bn 1.52 Bn
8 Encompass Health 12.25 Bn 12.72 Bn -
9 BrightSpring Health Services 11.87 Bn 10.21 Bn 492.75 Mn
10 GeneDx Holdings 1.67 Bn 1.04 Bn 78.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -1.28 Mn
API Access

GeneDx Holdings Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=WGS&period=max&api_key=YOUR_API_KEY